Discover trends, market shifts, and competitive outlooks for the allergic rhinitis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Allergic Rhinitis Market In 2029?

Recent years have witnessed a steady expansion of the allergic rhinitis market. It is forecasted to inflate from $15.22 billion in 2024 to $15.74 billion in 2025, marking a compound annual growth rate (CAGR) of 3.4%. Factors such as increasing exposure to allergens, shifting environmental conditions, heightened public awareness, escalating pollution levels, continuous research, and development in the field of allergic rhinitis and a rise in disposable incomes have contributed to the growth during the historic period.

The market size for allergic rhinitis is predicted to see sustained expansion in the coming years, reaching a valuation of $18.49 billion in 2029 with a 4.1% compound annual growth rate (CAGR). Conducive factors for the growth during the forecasted period include the need for preventive measures, an aging populace, urban progression, and healthcare expenditure. The period is also expected to feature significant trends like the use of biologics and monoclonal antibodies, application of digital health solutions, adoption of allergen evasion tactics, attention towards pediatric allergic rhinitis, and advancement in allergen detection technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

What Are the Core Growth Drivers Propelling the Allergic Rhinitis Market Forward?

Air quality and climate change have a significant impact on the growth of the allergic rhinitis market. The damaging substances released into our surroundings, known as air pollution, can negatively affect human health and the overall quality of life, including the air we breathe. Climate change, on the other hand, refers to shifts in climatic patterns over time such as temperature fluctuations and variations in precipitation. The connection between air quality, particularly pollution, and the prevalence of allergic rhinitis has increasingly become apparent, emphasizing their interplay concerning respiratory health. For instance, the United States Environmental Protection Agency disclosed that around 66 million tons of pollutants were released into the air across the US in 2023. Hence, air pollution and climate change contribute significantly to the surge in the allergic rhinitis market. The Allergic Rhinitis Market experiences a positive push due to the escalating use of corticosteroid treatment for patients suffering from allergic rhinitis. Steroid treatment or corticosteroid treatment essentially entails the usage of medicines called corticosteroids or steroids. The treatment is popular for allergic rhinitis as it helps to decrease inflammation in the nasal passages and soothe symptoms associated with this condition. For example, data from the American Society for Clinical Pharmacology and Therapeutics revealed that the average usage of oral corticosteroids was 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with yearly increases ranging from 0.1% to 0.17%. Most of these prescriptions were for short periods (1–29 days) and mainly for healthy adults suffering from temporary conditions like respiratory infections. Therefore, the growth of the allergic rhinitis market is being fuelled by the increase in corticosteroid treatment for the condition.

What Segment Types Define the Allergic Rhinitis Market Structure?

The allergic rhinitis market covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis

2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments

3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count

4) By Route Of Administration: Oral, Nasal, Other Route Of Administration

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores

Subsegments:

1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy

2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy

3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Allergic Rhinitis Market?

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Emerging Trends that Are Influencing the Allergic Rhinitis Industry Evolution?

Leading organizations in the allergic rhinitis market are innovating new medicines to maintain market stability. In August 2022, a prominent UK-based pharmaceutical firm, Hikma Pharmaceuticals PLC, together with the Switzerland-based Glenmark Specialty S.A., announced approval for Ryaltris, their joint product, by the United States Food and Drug Administration (FDA), a federal agency of the US. Remarkably, Ryaltris is the inaugural fixed-dose combination drug purposed for the treatment of both nasal and ocular symptoms stemming from seasonal allergic rhinitis, all in one convenient nasal spray suitable for adults and children 12 years old and above. Notably, nasal symptom relief begins a mere 15 minutes after the initial dose is taken.

View the full report here:

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

What Is the Definition of the Allergic Rhinitis Market?

Allergic rhinitis refers to an allergic reaction involving nasal inflammation brought on by an allergen, such as pollen, dust, mold, or animal skin flakes, resulting in sneezing, lung congestion, an itchy nose and a sore throat. Allergic rhinitis is treated with various allergy drugs in various dosage forms that help alleviate symptoms.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model